Detail of > 55661-38-6
- MSDS Download

- CAS Number:
- 55661-38-6
- Name:
Urea,N'-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-N-(2-chloroethyl)-N-nitroso-,hydrochloride (1:1)
- Superlist Name:
- Nimustine hydrochloride
- Formula:
- C9H13ClN6O2.ClH
- Molecular Structure:
![Molecular Structure of 55661-38-6 (Urea,N'-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-N-(2-chloroethyl)-N-nitroso-,hydrochloride (1:1))](http://www.lookchem.com/300w/2010/0622/55661-38-6.jpg)
- Synonyms:
- Urea,N'-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-N-(2-chloroethyl)-N-nitroso-,monohydrochloride (9CI);1-(4-Amino-2-methylpyrimidin-5-yl)methyl-3-(2-chloroethyl)-3-nitrosoureahydrochloride;ACNU;NSC-D 245382;Nidran;Nimustine hydrochloride;3-[(4-Amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride;N'-[(4-Amino-2-methyl-5-pyrimidinyl)methyl]-N-(2-chloroethyl)-N-nitrosourea hydrochloride;CS 439 HCl;CS-439;Nimustine HCl;
- Molecular Weight:
- 309.15
- Boiling Point:
- 471.6 °C at 760 mmHg
- Flash Point:
- 239 °C
- Appearance:
- white to light yellow solid.
- Hazard Symbols:
T- Risk Codes:
- 25
- Safety:
- 36/37/39-45Details
- Transport Information:
- UN 2811
- Deleted CAS:
- 52208-23-8
Related products
- 55661-38-6Urea,N'-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-N-(2-chloroethyl)-N-nitroso-,hydrochloride (1:1)
- 139549-68-1Pyridinium,1-dodecyl-, chloride, hydrate (1:1:1)
- 451524-43-91H-Imidazole,1-butyl-, tetrafluoroborate(1-) (1:1)
- 21121-22-2Triethanolamine sulphate (1:1)
- 456-14-4Benzenecarboximidamide,4-fluoro-, hydrochloride (1:1)
- 100224-74-6Guanidine; carbonate (1:1)
- 1039399-17-1PF-03654746, 4-methylbenzenesulfonate (1:1)
- 140-72-7Pyridinium,1-hexadecyl-, bromide (1:1)
Other Products
- Titanium Dioxide Carbon black Glutathione Adenosine Cable pulling lubricant
- 55661-38-6Urea,N'-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-N-(2-chloroethyl)-N-nitroso-,hydrochloride (1:1)
- 4707-16-8Benzenethiol,2,3,5,6-tetrachloro-
- 61788-90-7Amine oxides,cocoalkyldimethyl
- 90341-76-7C.I. Sulphur Blue 13
- 26095-59-0Otilonium bromide
- 77-75-81-Pentyn-3-ol,3-methyl-
- 4217-66-71,2-Propanediol,2-phenyl-
- 17577-28-5Phosphonium,(2-ethoxy-2-oxoethyl)triphenyl-, chloride (1:1)
- 38786-67-31-Propanone,2-bromo-1-(4-bromophenyl)-
- 13573-16-5Chromate(1-),diamminetetrakis(thiocyanato-kN)-, ammonium (1:1), (OC-6-11)-
- 53-16-7Estrone
- 150683-30-0Tolvaptan
- 64-31-3MORPHINE SULFATE
- 574-92-53-Quinolinecarboxylicacid, 4-hydroxy-7-(trifluoromethyl)-
- 52372-86-8L-Cysteine,N-acetyl-S-[5-(acetylamino)-2-hydroxyphenyl]-
Refine Suppliers Do you want your product ranking ahead? Know what is 'Top Seller'!
- Supplier Location:
China (Mainland)(18)
Hong Kong(1)
India(1)
- Business Type:
- Importer/Exporter(14)Lab/Research institutions(3)Manufacturers(1)
- Certificates:
- ISO(2) Production License (0)
Please post your buying leads,so that our qualified suppliers
will soon contact you!
*Required Fields
Reference
- Effect of total parenteral nutrition on the nutritional status and immunocompetence in host and on the tumor growth
- Effect of total parenteral nutrition on the nutritional status and immunocompetence in host and on the tumor growth. Nishijima, Muneyoshi; Ohyanagi, Harumasa; Saitoh, Yoichi (Sch. Med., Kobe Univ., Kobe, Japan). Nippon Geka Gakkai Zasshi, 85(7), 643-53 (Japanese) 1984. CODEN: NGGZAK. ISSN: 0301-4894. DOCUMENT TYPE: Journal CA Section: 1 (Pharmacology) Section cross-reference(s): 14, 15, 18 In rats with transplanted lung carcinoma, total parenteral nutrition resulted in accelerated tumor growth; thymidine kinase [9002-06-6] activity and mitotic index of the tumor was higher in these animals than in the low-calorie infusion group. Both the cellular and humoral immune systems were also more active in the well nourished rats. Although total parenteral nutrition had no effect on the chemotherapeutic efficacy of Adriamycin [23214-92-8] or ACNU [55661-38-6], the incidence of adverse effects from the antitumor drugs was lower and the survival rate after drug treatment was more favorable than in the low-calorie group.
- Preparation of liposome-encapsulated antitumor drugs; relationship between lipophilicity of drugs and in vitro drug release
- Preparation of liposome-encapsulated antitumor drugs; relationship between lipophilicity of drugs and in vitro drug release. Tsukada, Kazuhiro; Ueda, Seigo; Okada, Ryuzo (Prod. Dev. Lab., Sankyo Co., Ltd., Tokyo 140, Japan). Chem. Pharm. Bull., 32(5), 1929-35 (English) 1984. CODEN: CPBTAL. ISSN: 0009-2363. DOCUMENT TYPE: Journal CA Section: 63 (Pharmaceuticals) Liposomal encapsulation of drugs by a reverse-phase evapn. vesicle method was carried out, and the relation between the in vitro release rates and the lipophilicity of drugs was investigated. Carboquone [24279-91-2], nimustine (ACNU) [42471-28-3], nimustine-HCl [55661-38-6], cytosine arabinoside [147-94-4], 5-fluorouracil [51-21-8] and related compds. were used as model drugs. Encapsulation of the drugs in liposomes had no relation with the partition coeffs. of the drugs, whereas the in vitro release rate was highly correlated to the partition coeff. Evidently, the drug was released more slowly when the partition coeff. was lower. Therefore, to achieve sustained release of a drug by means of liposomal encapsulation, it would be necessary to decrease the partition coeff. of the drug by converting it into the hydrochloride form, as in the case of ACNU, or by forming the Na salt of the drug if the drug has a carboxylic acid group.
- About us
- |
- Payment
- |
- Contact us
- |
- Links
- |
- Help Center
- |
- Disclaimer
- |
- Add to favorite
- | SiteMap
- |
- Product SiteMap
- |
- Manufacturers
- |
- Suppliers
©2008 LookChem.com,License:ICP NO.:Zhejiang10014259
[Hangzhou]86-571-85317600,85317603,85317620

